Synonyms
Abuse potential
Definition
The abuse liability of a drug or a class of drugs is their propensity to be abused and produce adverse public health consequences. Although much of what constitutes abuse liability of a drug arises from the pharmacological properties of the drug itself (i.e., its ability to produce psychoactive effects associated with risk for abuse and/or addiction, also known as abuse potential), it can also be affected by social and cultural factors and may change from time to time as one drug or class of drug gains popularity in a particular culture. Individual products, even those containing the same generic drug, can differ in abuse liability, which may be determined by the specific formulation, the indication for which it is used, and other things, such as its market penetration and price.
Current Concepts and State of Knowledge
Background
One of the principal public health strategies for drug abuse prevention is to place regulatory controls on the...
References
Balster RL, Bigelow GE (2003) Guidelines and methodological reviews concerning drug abuse liability assessment. Drug Alcohol Depend 70(Suppl 3):S13–S40
Balster RL, Johanson C-E, Walsh SL (2009) Risk management and post-marketing surveillance of CNS drugs: an introduction. Drug Alcohol Depend 105(Suppl 1):S1–S3
Brady KT, Lydiard RB, Brady JV (2003) Assessing abuse liability in human trials. Drug Alcohol Depend 70:S87–S95
Comer SD, Ashworth JB, Foltin RW, Johanson CE, Zacny JP, Walsh SL (2008) The role of human drug self-administration procedures in the development of medications. Drug Alcohol Depend 96:1–15
Cone EJ, Giordano J, Weingarten B (2013) An iterative model for in vitro laboratory assessment of tamper deterrent formulations. Drug Alcohol Depend 131:100–105
Fraser HF, Van Horn GG, Martin WR, Wolbach AB, Isbell H (1961) Methods for evaluating addiction liability. (A) “Attitude” of opiate addicts toward opiate-like drugs, (B) a short-term “direct” addiction test. J Pharmacol Exp Ther 133:371–378
Haertzen CA (1966) Development of scales based on patterns of drug effects, using the addiction research center inventory (ARCI). Psychol Rep 18:163–194
Holtzman SG (1990) Discriminative stimulus effects of drugs: relationship to potential for abuse. In: Adler MW, Cowan A (eds) Testing and evaluation of drugs of abuse. Modem methods in pharmacology, vol 6. Wiley-Liss, New York, pp 193–210
Martin WR, Sloan BS, Sapira JD, Jasinski DR (1971) Physiologic, subjective and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine and methylphenidate in man. Clin Pharmacol Ther 12:245–258
Negus SS, Fantegrossi W (2008) Overview of conference on preclinical abuse liability testing: current methods and future challenges. Drug Alcohol Depend 92(CPDD News and Views):301–306
Nutt DJ, King LA, Nichols DE (2013) Effects of Schedule I drug laws on neuroscience research and treatment innovation. Nat Rev Neurosci 14:577–585
O’Connor AB, Turk DC, Dworkin RH, Colucci R, Haythornthwaite JA, Katz NP, Klein M, O’Brien C, Posner K, Rappaport BA, Reisfield G, Adams EH, Balster RL, Bigelow GE, Burke LB, Comer SD, Cone E, Cowan P, Denisco RA, Farrar JT, Foltin R, Haddox JD, Hertz S, Jasinski DR, Jay G, Johansson CE, Junor R, Kopecky E, Leiderman, DB, McDermott M, Palmer PP, Raja SN, Rauschkolb C, Rowbotham MC, Sampaio C, Setnick B, Smith SM, Sokolowska M, Stauffer JW, Walsh SL, Zacny JP (2013) Abuse liability measures for use in analgesic clinical trials in patients with pain; IMMPACT recommendations. Pain (in press)
Preston KL, Walsh SL (1998) Evaluating abuse liability: methods and predictive value. In: Karch SB (ed) Drug abuse handbook. CRC Press, Boca Raton, pp 276–306
Romach MK, Schoedel KA, Sellers EM (2013) Update on tamper-resistant drug formulations. Drug Alcohol Depend 130:13–23
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this entry
Cite this entry
Balster, R.L., Walsh, S.L. (2013). Abuse Liability Evaluation. In: Stolerman, I., Price, L. (eds) Encyclopedia of Psychopharmacology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-27772-6_30-2
Download citation
DOI: https://doi.org/10.1007/978-3-642-27772-6_30-2
Received:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Online ISBN: 978-3-642-27772-6
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences